Stanford scientists identified a naturally occurring molecule that suppressed appetite and promoted fat loss in animals. But the most intriguing finding wasn’t simply how much weight the animals lost. They appeared to lose fat while largely preserving muscle.
The molecule, called BRP, is attracting renewed attention following a ScienceDaily report. Unlike Ozempic, which affects receptors throughout the body, BRP appears to act more selectively on brain circuits regulating hunger. The findings are promising, although the research was originally published in 2025 and hasn’t established benefits in humans.
Related: Dave Bautista Lost 75 Pounds and Now He’s Bulking Up Again for a Very Different Role
Related: Wegovy Users Lost Weight, but Something Surprising Happened to Their Muscle
Stanford’s Weight-Loss Molecule Targets a Different Pathway
Researchers used artificial intelligence to identify BRP, a peptide consisting of just 12 amino acids. In experiments involving mice and minipigs, injections reduced food consumption by up to 50 percent during the following hour.
Advertisement
Advertisement
In obese mice, 14 days of treatment produced approximately three grams of weight loss, almost entirely from fat.
Stanford pathology professor Katrin Svensson, PhD, explained the biological distinction in the university’s original research announcement.
“The receptors targeted by semaglutide are found in the brain but also in the gut, pancreas and other tissues,” Svensson said.
“That’s why Ozempic has widespread effects including slowing the movement of food through the digestive tract and lowering blood sugar levels. In contrast, BRP appears to act specifically in the hypothalamus, which controls appetite and metabolism.”
Advertisement
Advertisement
Related: Ozempic Users Regained Two-Thirds of Their Weight After Stopping the Drug
The Biggest Advantage May Be What Doesn’t Disappear
Losing muscle alongside fat can undermine strength and mobility, particularly as people age. That’s why the composition of weight loss matters as much as the number on the scale.
The animal experiments also found no significant changes in movement, water intake, or fecal output, raising questions about whether BRP might eventually avoid certain digestive side effects.
Related: Ozempic and Wegovy Linked to Nasty Fingernail Problem, but There’s a Catch
Why This Isn’t an Ozempic Replacement Yet
BRP hasn’t demonstrated safety or effectiveness in human clinical trials. Researchers still need to identify its receptors, establish appropriate dosing, and determine whether its effects last.
Advertisement
Advertisement
Svensson emphasized the uncertainty: “Nothing we’ve tested before has compared to semaglutide’s ability to decrease appetite and body weight. We are very eager to learn if it is safe and effective in humans.”
For now, BRP offers an intriguing possibility, not a pharmacy-ready alternative. Anyone considering weight-loss medication should discuss established treatments with a clinician rather than betting on an experimental peptide.
Related: Wegovy Users Switched to a Daily Pill With Surprising Weight-Loss Results
Related: John Goodman Lost 200 Pounds, but One Change Still Takes Him by Surprise
This story was originally published by Men’s Journal on Nov 8, 2026, where it first appeared in the Health section. Add Men’s Journal as a Preferred Source by clicking here.
